1. | lotsofluck | |
2. | MindHealthYourself | |
3. | whnmil13 | |
4. | rickdl476 | |
5. | rdeenb |
1. | lotsofluck | |
2. | MindHealthYourself | |
3. | whnmil13 | |
4. | rickdl476 | |
5. | rdeenb |
1. | whnmil13 01/16/2018 Should have known |
2. | MindHealthYourself 11/10/2017 Short restriction never does anything in my opinion |
3. | MindHealthYourself 01/30/2018 Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) |
4. | MindHealthYourself 11/10/2017 Missed estimates = crushed |
5. | MindHealthYourself 03/30/2018 ActoBio Therapeutics Greenlighted by FDA to Commence a Phase Ib/IIa Trial with AG019 for the Treatment of Early Onset Type 1 Diabetes |
6. | rickdl476 01/30/2018 Deplorable, I dont get this stock |
7. | lotsofluck 11/10/2017 Short restriction on Monday and the stock is oversold PLUS at all times lows |
8. | lotsofluck 01/19/2018 Closing of Public Offering |
9. | rdeenb 08/09/2018 Misses EPS loss estimates by $0.28 and misses on revenues |
10. | MindHealthYourself 01/30/2018 Shocker {Image} |